logo
episode-header-image
Jul 2020
10m 59s

What We Know About Immunity

bloomberg
About this episode

In the race to study immunity to the virus, scientists first focused on antibodies -- proteins that stick to and disable foreign invaders. That’s because creating antibodies is the basis for most successful vaccines, so scientists are interested in learning who develops coronavirus antibodies, how long they stick around, and how effective they are at keeping people from getting infected again. But recent studies show there may be another weapon inside the human body that can rouse fresh antibody soldiers long after the first have left the battlefield. Bloomberg senior editor Jason Gale explains that T cells may be part of the key to blunting the coronavirus contagion.

See omnystudio.com/listener for privacy information.

Up next
Aug 2020
The Promise of a New Treatment
The drug company Eli Lilly is about to start testing its Covid-19 antibody drug in nursing homes. Vaccines may not work as well on elderly people or those with compromised immune systems. Since these are the very groups most at risk for severe disease or death if they contract th ... Show More
11m 32s
Aug 2020
Will Kids Spread COVID to Teachers?
Earlier this year, school gates around the world slammed shut. The drastic measure worked in many places. Now, as fall approaches, attention is turning back to a pillar of a pandemic-resilient society: schools. The role of children in driving transmission of the coronavirus isn’t ... Show More
14m 25s
Aug 2020
A Generation of Health Damage
The coronavirus has been spreading worldwide for over seven months now, and more than 18 million people are known to have been infected by it. Over that time, we’ve come to understand that, in most people, the virus causes mild symptoms or none at all -- at least at the time they ... Show More
13m 37s
Recommended Episodes
Dec 2023
Inhaled vaccine prevents COVID in monkeys
Current COVID-19 vaccines offer great protection from serious illness, but they don't prevent people from becoming infected in the first place. Because of this, researchers have been searching for ways to boost mucosal immunity — the immune response on mucosal surfaces — as this ... Show More
7m 54s
Sep 2021
Infection ou vaccination: laquelle procure la meilleure protection ?
<p>Il existe deux manières de développer une immunité au virus du Covid-19 : avoir été contaminé par ce virus ou avoir reçu deux doses de vaccin. Laquelle de ces deux méthodes est la plus efficace ?</p><br><p>L'infection conférerait une immunité moins efficace...</p><br><p>En pri ... Show More
2m 3s
Jul 2020
Demystifying the Vaccine
A recent vaccine trial from Oxford University shows promising preliminary results, suggesting the vaccine can produce immune responses that may protect people against infection. Dr. Sanjay Gupta spoke with Dr. Barney Graham, the deputy director of the Vaccine Research Center at t ... Show More
11m 17s
Jul 2020
Hopeful News About Antibodies
Throughout the pandemic there’s been a big question: Will recovering from the virus or being treated by an effective vaccine provide lasting immunity? CNN Contributor Erin Bromage shares why new studies from the last few weeks make him more hopeful than ever that the answer could ... Show More
9m 57s
Jun 2021
Covipod #9 : Le vaccin, moins efficace chez certaines personnes
<p>Aujourd'hui, dans Covipod, nous nous penchons sur le cas des personnes que les deux doses de vaccin ne suffisent pas à protéger contre la Covid-19, et sur les mesures à prendre pour s'assurer qu'elles n'attrapent pas la maladie. Nous ferons ensuite un bref état des lieux autou ... Show More
5m 43s
Aug 2021
TMHS 508: Covid-19 Vaccine Efficacy & Antibody Dependent Enhancement
We know that as viruses spread, their genetic makeup can change, meaning the virus can mutate into variants. In a scenario with mass vaccination, a mechanism called antibody-dependent enhancement can occur. This means that instead of stopping an infection, antibodies actually can ... Show More
1h 9m